Abiopharma

Clinical trial NCT06365723 updates: 1. completion date: 2027-11-30 → 2028-11-30 2. primary completion date: 2027-11-30 → 2028-11-30

Clinical trial NCT07214766 updates: 1. enrollment: 312 → 331 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06035744 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-06-01 → 2026-06-16 3. primary completion date: 2028-06-01 → 2026-06-16 4. enrollment: 86 → 23 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07613294 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-02

Clinical trial NCT06529822 updates: 1. completion date: 2033-03-31 → 2034-06-30 2. primary completion date: 2028-10-31 → 2030-01-31 3. enrollment: 32 → 64 participants

Clinical trial NCT05389449 updates: 1. completion date: 2026-07-31 → 2026-08-24 2. primary completion date: 2026-07-31 → 2026-08-24

Clinical trial NCT07557420: enrollment: 19 → 21 participants.

Clinical trial NCT06329401: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05708950 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-12-31 → 2025-12-18 3. primary completion date: 2024-06-30 → 2025-10-16 4. enrollment: 314 → 40 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05140954: start date: 2023-03-28 → 2023-04-10.